Karolinska University Hospital
Stockholm, 17176, Sweden
NCT Number: NCT03998579
The main objective of the CanMoRe study is to evaluate the impact of a standardized and individually adapted exercise intervention in Primary Health Care aiming at improving physical function (primary outcome) and habitual physical activity, health related quality of life, fatigue and psychological well-being in patients undergoing radical cystectomy due to urinary bladder cancer.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Stockholm, 17176, Sweden
The most common treatment for solid cancer tumours is surgery, often in combination with chemo- and/or radiotherapy. To minimise the postoperative complications is important in today's health care. Early mobilisation at the ward and physical activity at home after discharge, have been shown to be important parts to reduce complications. Common complications after abdominal surgery are postoperative pulmonary complications and venous thrombosis. One of the conditions that suffers the most from different kinds of postoperative complications is radical cystectomy due to urinary bladder cancer. Complications after radical cystectomy could be direct related to the patients' high age and also high degree of comorbidity.
There is today strong evidence that physical activity has a positive impact on health, survival and quality of life. Patients who have been treated for urinary bladder cancer are not sufficiently physical active and suffer from readmissions to hospital due to complications. Therefore, there is a need for developing and testing a physical rehabilitation programme to support patients who have a radical cystectomy, in the early postoperative period.
The CanMoRe study is a randomized controlled trial with a single-blinded design evaluating an exercise intervention in Primary Health Care as part of the CanMoRe programme. In addition, a qualitative study (interviews) on patient's experience of the programme will be conducted as well as data gathered on factors that might influence the implementation of the programme.
Then CanMoRe programme consists of preoperative information, the Activity Board used for enhanced mobilization during hospital stay, a 12-week, (1 h, 2 times/week) standardized and individually adapted exercise intervention in Primary Health Care and behavioral support for daily physical activity. The CanMoRe programme is evaluated in two steps, i.e. the in-hospital intervention using the Activity Board (published) and the exercise intervention in Primary Health Care reported herein.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An exercise intervention in Primary Health Care
An active control group
Time frame: Change from baseline to after 12 weeks intervention
The test reproduces activity of daily living at a sub maximal level. Output: meters Score: 0-900.
Time frame: Measurement 1: Baseline, Measurement 2: After 12 weeks intervention. Measurement 3: 1 year after discharge
Habitual physical activity, measured for 7 consecutive days. Output: number of steps per day.
Time frame: Measurement 1: Baseline, Measurement 2: After 12 weeks intervention. Measurement 3: 1 year after discharge
Measure of leg strength. Output: Scale 0-30
Time frame: Measurement 1: Baseline, Measurement 2: After 12 weeks intervention. Measurement 3: 1 year after discharge,
Measure of hand grip strength (Jamar hand dynamometer). Output: Kilo 0-60
Time frame: Measurement 1: Baseline Measurement 2: After 12 weeks intervention. Measurement 3: 1 year after discharge
Health related quality of life. Output: Scale 0-100. A higher score is worse outcome. For more information see https://qol.eortc.org/questionnaires/
Time frame: Measurement 1: Baseline Measurement 2: After 12 weeks intervention. Measurement 3: 1 year after discharge
Health related quality of life specific for bladder cancer Output: Scale 0-100, a higher score is worse
Time frame: Measurement 1: Baseline, Measurement 2: After 12 weeks intervention. Measurement 3: 1 year after discharge
Fatigue. Output: Scale 0-10. A higher score is worse, i.e more fatigue
Time frame: Measurement 1: Baseline, Measurement 2: After 12 weeks intervention. Measurement 3: 1 year after discharge
Pain. Output: Scale 0-10, A higher score is worse i.e more pain
Time frame: Measurement 1: Baseline, Measurement 2: 12 weeks. Measurement 3: 1 year after discharge
Psychological wellbeing. Output: Scale 0-21. A higher score is worse
Time frame: Collected from journals using standardized time frames at 30 and 90 days
Readmissions to hospital. Output: Yes/No
Time frame: Collected from journals using standardized time frames at 30 and 90 days
Complications such as Pneumonia Output: according to Clavien - Dindo classification
Time frame: Measurement 3: 1 year after discharge
The test reproduces activity of daily living at a sub maximal level. Output: meters Score: 0-900.
Karolinska Institutet
Other
The Effect of Physical Rehabilitation Among Patients Undergoing Radical Cystectomy Due to Urinary Bladder Cancer - the CanMoRe Study
Acronym: CanMoRe
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07259798
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cairo, Abbasia, Egypt
View Trial DetailsNCT06582849
Adnexal Diseases, Anal Cancer
St Louis, Missouri, United States
View Trial DetailsNCT03433924
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Beijing, China
View Trial DetailsNCT06156787
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Darfur, Sudan
View Trial Details